Your search for ‘Potter Clarkson’ returned 396 results

Polycystic Ovary Syndrome has been officially renamed Polyendocrine Metabolic Ovarian Syndrome following a 14-year global medical consensus. The new terminology better reflects the condition's complex hormonal, metabolic and reproductive nature, moving beyond the misleading reference to ovarian cysts. What does this fundamental shift in medical understanding mean for patent applications and intellectual property strategy in women's health innovation?

In June this year Europol Operation Pirates 1 took place seizing fake goods including counterfeit pharmaceuticals worth over €33m. Then between April and October...